SCHEMBL8039797

SCHEMBL8039797

c1ccc(-c2cc(CNCC3CCCCC3)no2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.54
NOTUM Q6P988 1/20 0.54
CRHR1 P34998 1/20 0.52
S1PR1 P21453 2/20 0.51
RAB9A P51151 7/20 0.49
NPC1 O15118 4/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
ALDH1A1 P00352 2/20 0.49
TDP1 Q9NUW8 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
S1PR3 Q99500 1/20 0.48
IDO1 P14902 1/20 0.47
KMT2A Q03164 2/20 0.46
LMNA P02545 1/20 0.46
HPGD P15428 1/20 0.46
FAAH O00519 1/20 0.46
KDM4E B2RXH2 1/20 0.45
ATM Q13315 1/20 0.45
SLC6A9 P48067 1/20 0.44
WNK1 Q9H4A3 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8809493 0.81 S1PR1 (0.56) HIF1ANOTUMS1PR1RAB9ANPC1
SCHEMBL17933815 0.74 HIF1A (0.90) HIF1AS1PR1RAB9ANPC1SMN1; SMN2
SCHEMBL4902504 0.73 RAB9A (0.65) HIF1ANOTUMRAB9ANPC1SMN1; SMN2
SCHEMBL14606631 0.72 ALKBH5 (0.49) RAB9ANPC1IDO1WNK1HDAC3
SCHEMBL21696743 0.72 S1PR1 (0.50) HIF1ANOTUMS1PR1RAB9ANPC1
SCHEMBL31686265 0.71 NOTUM (0.59) HIF1ANOTUMRAB9ANPC1SMN1; SMN2
SCHEMBL7603669 0.71 CXCR4 (0.63) RAB9ANPC1HPGDHDAC3HDAC1
SCHEMBL10764797 0.71 CXCR4 (0.63) RAB9ANPC1HPGDHDAC3HDAC1
SCHEMBL1544128 0.71 NOTUM (1.00) HIF1ANOTUMRAB9ANPC1SMN1; SMN2
SCHEMBL3122505 0.71 HPGD (0.68) RAB9ANPC1SMN1; SMN2ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009071706-A1 PYRAZOLEPYRIMIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES GALAPAGOS NV (BE) 2009-06-11 WO disclosed